Skip to main content
. 2023 Nov 2;26(6):540. doi: 10.3892/ol.2023.14127

Figure 6.

Figure 6.

Effects of DHA treatment, CaMKK2-OE and NCLX siRNA on the actin cytoskeleton. (A) Phalloidin staining and (B) relative expression of F-actin in HepG2 cells treated with DHA, CaMKK2-OE and/or NCLX siRNA. (C) Phalloidin staining and (D) relative expression of F-actin in HuH-7 cells treated with DHA, CaMKK2-OE and/or NCLX siRNA. All data are presented as the mean ± standard deviation (n=3). Data were analyzed using one-way analysis of variance followed by Bonferroni post hoc test. Scale bar, 20 µm *P<0.05; **P<0.01; ***P<0.001. NCLX, mitochondrial sodium/calcium exchanger protein; DHA, dihydroartemisinin; CaMKK2, calcium/calmodulin-dependent protein kinase kinase 2; OE, overexpression; ns, not significant; NC, negative control.